Android app on Google Play

Nabi Biopharmaceuticals (NABI) Reports Q4 Loss of $0.05

March 14, 2012 4:15 PM EDT Send to a Friend
Get Alerts NABI Hot Sheet
Trade NABI Now!
Join SI Premium – FREE
Nabi Biopharmaceuticals (NASDAQ: NABI) reported Q4 EPS of ($0.05), versus ($0.08) reported last year.

For earnings history and earnings-related data on Nabi Biopharmaceuticals (NABI) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment